HighTower Advisors LLC Has $897,000 Stock Holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

HighTower Advisors LLC lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 1.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,653 shares of the company’s stock after buying an additional 261 shares during the period. HighTower Advisors LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $897,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the business. Raymond James Financial Inc. bought a new position in iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at about $4,472,000. Pallas Capital Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at approximately $3,829,000. Strategic Financial Concepts LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at approximately $1,312,000. Grimes & Company Inc. acquired a new position in iShares U.S. Pharmaceuticals ETF during the 4th quarter worth approximately $967,000. Finally, Jones Financial Companies Lllp lifted its stake in iShares U.S. Pharmaceuticals ETF by 74.6% in the 4th quarter. Jones Financial Companies Lllp now owns 30,913 shares of the company’s stock valued at $2,032,000 after purchasing an additional 13,209 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $68.78 on Friday. The company’s 50 day moving average price is $70.11 and its two-hundred day moving average price is $69.29. The firm has a market capitalization of $605.26 million, a P/E ratio of 25.04 and a beta of 0.63. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $62.68 and a fifty-two week high of $73.28.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.